Dextrose Solution
NDC Package 0264-7520-20
Package Information
Dextrose solution is dextrose Injection (5% and 10%) is indicated as a source of water and calories in adult and pediatric patients, and may also be used as a diluent for reconstitution of a powder or liquid drug product. This formulation utilizes a solution delivery system. Marketed by B. Braun Medical Inc., this product is identified by NDC 0264-7520 and is authorized under FDA application NDA019626.
Identification & Billing
- RxCUI: 1795477 - dextrose 10 % in 500 ML Injection
- RxCUI: 1795477 - 500 ML glucose 100 MG/ML Injection
- RxCUI: 1795477 - dextrose 10 % per 500 ML Injection
- RxCUI: 1795480 - dextrose 10 % in 250 ML Injection
- RxCUI: 1795480 - 250 ML glucose 100 MG/ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0264 - B. Braun Medical Inc.
- 0264-7520 - Dextrose
- 0264-7520-20 - 24 CONTAINER in 1 CASE / 250 mL in 1 CONTAINER
- 0264-7520 - Dextrose
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0264-7520). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0264-7520-20 identifies a specific commercial package of 24 container in 1 case / 250 ml in 1 container of Dextrose, a human prescription drug labeled by B. Braun Medical Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 6000 billable units per package. This solution is formulated for intravenous use and contains dextrose, unspecified form as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by B. Braun Medical Inc. on February 02, 1988. The current certification is valid through December 31, 2027.
How is this B. Braun Medical Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00264752020. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 6000 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.